DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Private Equity
Greenwich, CT
We manage two separate, but highly complementary investment strategies – lower middle market growth buyout funds investing in private health care companies and a hedge fund investing in public life sciences companies.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures, news and newswire. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| GPP IV - Ludi, LLC | 2024 | Unknown | Private Equity Fund | n/a | $2.7M | 0 |
| GPP III - Ixcells, LLC | 2023 | Unknown | Private Equity Fund | n/a | $1.6M | 0 |
| GPP III - Ephicacy, LLC | 2023 | Unknown | Private Equity Fund | n/a | $20.8M | 0 |
| GPP - Cf I, LP | 2023 | Unknown | Private Equity Fund | n/a | $29.6M | 0 |
| Great Point Partners IV, L.P. | 2022 | Early deployment | Private Equity Fund | n/a | $535M | 0 |
| GPP III - Pcm, LLC | 2022 | Unknown | Private Equity Fund | n/a | $31.3M | 0 |
| GPP Ii-A Salmon Aiv, L.P. | 2021 | Wound down | Private Equity Fund | n/a | $20.6M | 0 |
| GPP III - Mlm, LLC | 2021 | Active deployment | Private Equity Fund | n/a | $5.3M | 0 |
| Great Point Partners II Salmon Aiv, L.P. | 2021 | Wound down | Private Equity Fund | n/a | $67.1M | 0 |
| GPP III - Tergus, LLC | 2020 | Successor fundraising | Private Equity Fund | n/a | $538,337 | 0 |
| Great Point Partners Iii-A, L.P. | 2020 | Mature | Private Equity Fund | n/a | $51.3M | 0 |
| GPP III - Axiom, LLC | 2020 | Successor fundraising | Private Equity Fund | n/a | $14.7M | 0 |
| GPP II - Steripack, LLC | 2020 | Wound down | Private Equity Fund | n/a | $32.2M | 0 |
| GPP III - Bionova, LLC | 2020 | Successor fundraising | Private Equity Fund | n/a | $136,051 | 0 |
| GPP II - Masthercell, LLC | 2019 | Wound down | Private Equity Fund | n/a | $15.0M | 0 |
| GPP II - Mdrs Holdings, LLC | 2019 | Mature | Private Equity Fund | n/a | $553,596 | 0 |
| Great Point Partners III, LP | 2019 | Successor fundraising | Private Equity Fund | n/a | $291M | 0 |
| GPP II - Ucs, LLC | 2018 | Harvest | Private Equity Fund | n/a | $2.2M | 0 |
| GPP II - Abr, LLC | 2017 | Wound down | Private Equity Fund | n/a | $64,724 | 0 |
| GPP - Ohs, LLC | 2016 | Wound down | Private Equity Fund | n/a | $36,047 | 0 |
| GPP I - Pcf, LLC | 2016 | Wound down | Private Equity Fund | n/a | $3,314 | 0 |
| GPP I - Ah, LLC | 2016 | Wound down | Private Equity Fund | n/a | $658,595 | 0 |
| GPP I - Cytovance, LLC | 2016 | Wound down | Private Equity Fund | n/a | $37,951 | 0 |
| GPP Ii-Corrona, LLC | 2015 | Wound down | Private Equity Fund | n/a | $819,740 | 0 |
| GPP - Salmon Co-Invest, L.P. | 2015 | Mature | Private Equity Fund | n/a | $2.2M | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Beneficial In-Home Care | n/a | Add on | control | Feb 6, 2025 | n/a | active |
| Eutecma | n/a | unknown | unknown | Jan 1, 2025 | n/a | active |
| Lenis | n/a | unknown | unknown | Jan 1, 2025 | n/a | active |
| Pyramids Pharmacy | n/a | unknown | unknown | Jan 1, 2025 | n/a | active |
| Award-Winning akt health communications | n/a | Add on | control | Jul 22, 2024 | n/a | active |
| BioCentric, Inc. | n/a | Add on | control | May 23, 2024 | n/a | active |
| Advance Research Associates | n/a | Add on | control | May 2, 2024 | n/a | active |
| Specialty Service Solutions, LLC | n/a | Add on | control | May 2, 2024 | n/a | active |
| Lyocontract | n/a | unknown | unknown | Jan 1, 2024 | n/a | active |
| True North Solutions, Inc. | n/a | Add on | control | Oct 18, 2023 | n/a | active |
| Companion Care | n/a | Add on | control | Aug 9, 2023 | n/a | active |
| Ludi | n/a | platform | control | Jan 1, 2023 | n/a | active |
| E-Therapy | n/a | unknown | unknown | Jan 1, 2022 | n/a | exited |
| Ephicacy | n/a | unknown | unknown | Jan 1, 2022 | n/a | active |
| JPA Health | n/a | platform | unknown | Jan 1, 2022 | n/a | active |
| iXCells Biotechnologies | n/a | unknown | unknown | Jan 1, 2022 | Mar 24, 2026 | exited |
| VetnCare | n/a | unknown | unknown | Jan 1, 2022 | n/a | active |
| Velentium | n/a | platform | control | Sep 29, 2021 | n/a | active |
| Adeo In Home Care | n/a | Add on | control | Jun 23, 2021 | n/a | active |
| Helping Hands Home Care | n/a | Add on | control | Jun 23, 2021 | n/a | active |
| Kozani Health | n/a | Add on | control | Apr 5, 2021 | n/a | active |
| Cellipont Bioservices | n/a | unknown | unknown | Jan 1, 2021 | n/a | active |
| Velentium Medical | n/a | unknown | unknown | Jan 1, 2021 | n/a | active |
| Family Resource Home Care | n/a | platform | unknown | Jan 1, 2020 | n/a | active |
| Axiom | n/a | unknown | unknown | Jan 1, 2019 | n/a | exited |
| Bionova Scientific | n/a | unknown | unknown | Jan 1, 2019 | n/a | active |
| Little Spurs | n/a | unknown | unknown | Jan 1, 2019 | n/a | active |
| MLM Medical Labs | n/a | platform | unknown | Jan 1, 2019 | n/a | active |
| SteriPack | n/a | unknown | unknown | Jan 1, 2019 | n/a | active |
| Tergus Pharma | n/a | unknown | unknown | Jan 1, 2019 | n/a | exited |
Also named here, with no published line of their own (reach them through the firm): Alex Gulotta (Senior Vice President), Alex Gulotta (Senior Vice President), Noah Rhodes (Managing Director), Eddie Hjerpe (Vice President), Noah Rhodes (Managing Director), Eddie Hjerpe (Vice President), Adam Dolder (Managing Director), Adam Dolder (Managing Director), Stephen Weaver (Senior Vice President), Stephen Weaver (Senior Vice President).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan